ABBV-400 Demonstrates Preliminary Efficacy, Safety in MSS/pMMR Advanced CRC Read More » August 8, 2024
FDA Awards Orphan Drug Designation to Avutometinib Plus Defactinib in Pancreatic Cancer Read More » August 7, 2024
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment Read More » July 29, 2024
Additional Data Published in “Annals of Surgical Oncology” Recommends Extended Monitoring of Lymphedema for Breast Cancer Patients Read More » July 29, 2024
Biotheryx Announces First Patient Dosed in Phase 1 Clinical Trial of BTX-9341, a First-in-Class, Dual Bifunctional Degrader of CDK4/6, as a Monotherapy and in Combination with Fulvestrant for HR+/HER2- Breast Cancer Read More » July 29, 2024
Tufts Medical Center Becomes First Hospital in Massachusetts to Adopt MOLLI Surgical’s Breast Cancer Technology Read More » July 29, 2024
The Pursuit of Targeted Agents Broadens the HR+ Breast Cancer Treatment Paradigm Read More » June 28, 2024
Tucatinib-Based Regimen Improves Target Deficits, QOL in HER2+ Breast Cancer With Leptomeningeal Metastasis Read More » June 28, 2024
DESTINY-Breast Trial Portfolio Spotlights Efficacy of T-DXd in Metastatic Breast Cancer Read More » June 28, 2024
